Somatostatin analogs for diagnosis and treatment of cancer
- 31 December 1993
- journal article
- review article
- Published by Elsevier BV in Pharmacology & Therapeutics
- Vol. 60 (2), 245-264
- https://doi.org/10.1016/0163-7258(93)90009-3
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Multiple Gene Transcripts of the Somatostatin Receptor SSTR2: Tissue-Selective Distribution and cAMP RegulationBiochemical and Biophysical Research Communications, 1993
- The Rat SSTR2 Somatostatin Receptor Subtype Is Coupled to Inhibition of Cyclic AMP AccumulationBiochemical and Biophysical Research Communications, 1993
- Inhibition of gastrin-stimulated growth of gastrointestinal tumour cells by octreotide and the gastrin/cholecystokinin receptor antagonists, proglumide and lorglumideEuropean Journal Of Cancer, 1992
- In vivo application of [111In-DTPA-D-Phe1]-octreotide for detection of somatostatin receptor-positive tumors in ratsLife Sciences, 1991
- [111In-DTPA-D-Phe1]-octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: synthesis, radiolabeling and in vitro validationLife Sciences, 1991
- What Is the Evidence That Tumors Are Angiogenesis Dependent?JNCI Journal of the National Cancer Institute, 1990
- In vitro and in vivo inhibition of human small cell lung carcinoma (NCl-H69) growth by a somatostatin analogueBiochemical and Biophysical Research Communications, 1988
- Inhibition of rat prostate tumor growth by an octapeptide analog of somatostatinLife Sciences, 1987
- SomatostatinNew England Journal of Medicine, 1983
- SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged actionLife Sciences, 1982